Clinical Evaluation of Live Combined Bifidobacterium,Lactobacillus and Enterococcus and Domperidone Combined with Moxibustion in the Treatment of Gastrointestinal Dysfunction Induced by Newly-Diag-nosed Cerebral Infarction During the Recovery Period
Objective To investigate the clinical efficacy of live combined Bifidobacterium,Lactobacillus and Enterococcus and domperidone combined with moxibustion in the treatment of gastrointestinal dysfunction induced by newly-diagnosed cerebral infarction during the recovery period.Methods A total of 242 patients experiencing gastrointestinal dysfunction during the recovery period of cerebral infarction admitted to the hospital from August 2021 to April 2024 were selected and divided into the control group and the observation group by the random number table method,with 121 cases in each group.The patients in the two groups were given Domperidone Tablets and Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules,Oral,on this basis,the patients in the observation group were given moxibustion on the bilateral Zusanli,Ganshu and Shenshu acupoints.Both groups were treated for four weeks.Results The total effective rate in the observation group was 96.69％,which was significantly higher than 92.56％in the control group(P＜0.05).Compared with those in the control group,the Bifidobacterium and Lactobacillus counts significantly increased in the observation group after treatment,Enterobacter and Enterococcus counts significantly decreased,gastrin(GAS),motilin(MTL),total protein(TP),and albumin(Alb)levels significantly increased,the scores of various items on the Gastrointestinal Symptom Rating Scale(GSRS)significantly decreased(P＜0.05).Conclusion Live combined Bifidobacterium,Lactobacillus and Enterococcus and domperidone combined with moxibustion can improve the intestinal flora structure and gastrointestinal symptoms in patients with gastrointestinal dysfunction induced by newly-diagnosed cerebral infarction during the recovery period.
万方数据
维普
